Correlation between morphologic and other prognostic markers of neuroblastoma a study of histologic grade, DNA index, N‐myc gene copy number, and lactic dehydrogenase in patients in the pediatric oncology group
暂无分享,去创建一个
A. Look | J. Shuster | J. Silverman | E. W. Larkin | H. T. Norris | A. Cantor | G. Brodeur | F. A. Hayes | R. Castleberry | E. I. Smith | V. Joshi | G. Altshuler | C. Holbrook | C. T. Holbrook
[1] J. Shuster,et al. Serum Lactate Dehydrogenase in Childhood Neuroblastoma A Pediatric Oncology Group Recursive Partitioning Study , 1992, American journal of clinical oncology.
[2] K. Alitalo,et al. Alternative Forms of Max as Enhancers or Suppressors of Myc-Ras Cotransformation , 1992, Science.
[3] J. Shuster,et al. Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the pediatric oncology group , 1992, Cancer.
[4] J. Shuster,et al. Age‐linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the pediatric oncology group , 1992, Cancer.
[5] M. Schwab,et al. The N‐Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells. , 1991, The EMBO journal.
[6] A T Look,et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] T. Jahnsen,et al. N-myc amplification in neuroblastomas: histopathological, DNA ploidy, and clinical variables. , 1989, Journal of clinical pathology.
[8] J. Wasson,et al. Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. , 1987, Cancer research.
[9] H. Sather,et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.
[10] H. Sather,et al. Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience. , 1985, Cancer research.
[11] H. B. Marsden,et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. , 1984, Journal of the National Cancer Institute.
[12] A. Look,et al. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. , 1984, The New England journal of medicine.
[13] H. Varmus,et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.
[14] J. Trent,et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour , 1983, Nature.
[15] A. Feinberg,et al. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.
[16] K. Yanagi,et al. Selective staining by 4', 6-diamidine-2-phenylindole of nanogram quantities of DNA in the presence of RNA on gels. , 1979, Nucleic acids research.
[17] J. Kapuściński,et al. Simple and rapid fluorimetric method for DNA microassay. , 1977, Analytical biochemistry.
[18] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[19] N. Breslow,et al. Statistical estimation of prognosis for children with neuroblastoma. , 1971, Cancer research.